Ebola virus mutates or affect the efficacy of new drugs
The 20th US researchers say they have found a genetic variation of Ebola occurred in the past 40 years, these mutations may affect the efficacy of drugs being developed for Ebola.
monoclonal antibodies
Nature magazine published an article commemorating 50 years found that B lymphocytes
the core issue is the vertebrate immunology research how to adjust their defense in response to bacteria and viruses, the latter two chemicals showed almost unlimited diversity. Good laboratory in adding two years, Cooper made a discovery on lymphocytes, which are proven to crack the mystery and eventually unify these two camps in the area of research played a crucial role.